Premas Biotech SARS-Cov-2 vaccine candidate moves ahead for animal trials
Gurgaon-based Premas Biotech, which developed the world’s first triple antigen virus-like particle (VLP) vaccine candidate for SARS CoV-2 virus,announces that […]
Say something
Gurgaon-based Premas Biotech, which developed the world’s first triple antigen virus-like particle (VLP) vaccine candidate for SARS CoV-2 virus,announces that […]